Jan 26, 2017 13:30 pm UTC| Business
WIXOM, Mich., Jan. 26, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
PRA Group Announces the Sale of Government Services Business
Jan 26, 2017 13:30 pm UTC| Business
NORFOLK, Va., Jan. 26, 2017 -- PRA Group, Inc. (Nasdaq:PRAA), a global leader in acquiring nonperforming loans, today announced the sale of its Government Services fee-for-service business for $91.5 million in cash plus...
Jan 26, 2017 13:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2017 -- Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that data...
West Bancorporation, Inc. Announces Record Net Income, Declares Quarterly Dividend
Jan 26, 2017 13:30 pm UTC| Business
WEST DES MOINES, Iowa, Jan. 26, 2017 -- West Bancorporation, Inc. (NASDAQ:WTBA), parent company of West Bank, is pleased to report that fourth quarter 2016 net income was $6.0 million, or $0.37 per diluted common share....
Truxton Corporation Reports Fourth Quarter 2016 Results
Jan 26, 2017 13:30 pm UTC| Business
NASHVILLE, Tenn., Jan. 26, 2017 -- Truxton Corporation (OTCPK:TRUX), a financial holding company and the parent of Truxton Trust Company (the “Bank”), reported consolidated net income of $1,682,000 for the fourth...
Lance Brinker Joins ABT’s Board of Directors
Jan 26, 2017 13:30 pm UTC| Business
Pasadena, CA, Jan. 26, 2017 -- ABT Holdings (OTC Pink: ABOT), at times, referred to as “ABT or the “Company,” today announced that Lance Brinker, a former divisional head of UPS, has been elected to ABT’s Board of...
Cellectar Biosciences to Present at NobleCon13
Jan 26, 2017 13:30 pm UTC| Business
MADISON, Wis., Jan. 26, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announced today that its president and CEO, Jim Caruso, will present at NobleCon13,...